Teladoc Shares Jump on Narrower-Than-Feared Q2 Loss, Revenue Beats

Investing.com
Jul 30

Teladoc Health Inc (NYSE:TDOC) shares jumped 3.2% after the virtual care provider reported better-than-expected second quarter revenue and a narrower loss than analysts had anticipated, despite ongoing challenges in its BetterHelp segment.

The company posted revenue of $631.9 million for the second quarter, exceeding analyst estimates of $622.54 million, though this represented a 2% decline YoY. Teladoc reported a loss of $0.19 per share, better than the analyst consensus of $0.26 per share. The results showed continued strength in the company’s Integrated Care segment, which grew 4% YoY to $391.5 million, offsetting weakness in its BetterHelp segment, which declined 9% YoY to $240.4 million.

"I’m pleased with our performance in the second quarter, with consolidated revenue and adjusted EBITDA both at the higher end of our guidance ranges," said Chuck Divita, Chief Executive Officer of Teladoc Health. "This reflects continued disciplined execution and builds on our solid results from the first quarter."

The company’s U.S. Integrated Care membership grew 11% YoY to 102.4 million members, though BetterHelp paying users decreased 5% to 388,000. Adjusted EBITDA fell 23% to $69.3 million, with margins declining in both segments.

For the third quarter, Teladoc expects revenue between $614 million and $636 million, compared to analyst estimates of $627.9 million. The company forecasts a loss of $0.20 to $0.35 per share for Q3, versus the consensus of $0.24 per share.

Teladoc also maintained its full-year 2025 revenue guidance of $2.50 billion to $2.55 billion, with an expected loss of $1.00 to $1.35 per share. The company recently secured a five-year, $300 million senior secured revolving credit facility, which it says will enhance financial flexibility.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10